Latest stories on CGEN
Solid Cash Position and Advancing Clinical Trials Define Compugen’s Q1 2026 Results
MarketChameleon67 · bullishearnings
Compugen: 'Buy' As Early Gastric Cancer Data Reinforces Rilvegostomig Program
Seeking Alpha61 · neutralanalyst
Compugen Ltd. (CGEN) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Compugen Q1 Earnings Call Highlights
Yahoo Finance53 · neutralearnings
Compugen surges after revenue tops forecasts despite quarterly loss miss (CGEN)
Yahoo Top68 · bullishearnings
Compugen GAAP EPS of -$0.08 misses by $0.01, revenue of $2.18M beats by $0.92M
Seeking Alpha42 · neutralearnings
Compugen Q1 2026 Earnings Preview
Seeking Alpha47 · neutralearnings
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum
PR Newswire53 · neutralproduct/pr